MATERIALS AND METHODS

Patients
The study was conducted in the NICU of the Neonatal and Maternity Center of Tunis (Tunisia) over a period of 1 year (January 2007 to December 2007) after approval by the ethical committee of the center. The patients were enrolled after written informed consent was obtained from their parents. The criteria for enrollment were as follows: gestational age Ͻ 32 weeks; birth weight Ͻ 1500 g; postnatal age between 48 and 96 hours; respiratory distress requiring Ͼ25% oxygen supplementation; and echocardiographic evidence of significant leftto-right shunting across PDA. Exclusion criteria were: right-to-left shunting; major congenital anomalies; IVH grade 3-4; tendency to bleed (defined by the presence of blood in endotracheal aspirate, gastric aspirate, stools or urines, and/or by oozing from puncture sites); serum creatinine level of Ͼ16 mg/dL; serum urea nitrogen level of Ͼ9 mg/dL; and a platelet count of Ͻ60 000/L. The presence of a single exclusion criterion was enough to exclude the patient from the study.
Study Design
The patients were randomly assigned to a treatment group by means of cards in sealed opaque envelopes. Each enrolled patient received a dose of 10 mg/kg of either oral (group O) or intravenous (group I) ibuprofen. After the first dose of treatment in both groups, echocardiographic evaluation was performed to determine the need for a second or a third dose. In each group, in case the ductus was still open after the third dose, intravenous ibuprofen (an initial dose of 10 mg/kg followed by 2 doses of 5 mg/kg each, after 24 and 48 hours) as a nonrandomized rescue treatment was given. If this therapy also failed to promote ductal closure and the patient continued to receive mechanical ventilation, surgical ligation of the ductus was performed. In each group, in case there was only minor ductal shunting after therapy and the patient did not require respiratory support, no additional treatment of the ductus was attempted. Oral ibuprofen (Ibuphil, Simed, Tunisia; a bottle of 125 mL containing 2.5 g of ibuprofen, 1 mL equals 20 mg of ibuprofen; pH: 5.8; osmolarity: 312 mosmol/L) was diluted in 3 mL of saline solution and then administered through a feeding tube, followed by flushing with distilled water. Intravenous ibuprofen (Pedea, Orphan Europe; a vial of 2 mL containing 10 mg of ibuprofen) was infused continuously over a period of 15 minutes. Tolerance was assessed daily during the week after the beginning of treatment by clinical examination (tendency to bleed, abdominal bloating, urine output), cranial ultrasound examination (IVH, change in grade), and laboratory tests (serum creatinine and serum urea nitrogen levels). Oliguria was defined as a urine output of 1 mL/kg per hour or less during a 24-hour collection period. Occurrence of any of the following conditions was enough to discontinue treatment: IVH grade 3-4, renal failure, NEC, and gastrointestinal bleeding (GEB).
Color Doppler Echography
In each enrolled patient, color Doppler echography (model SSA-350A, 7-MHz transducer [Toshiba, Tokyo, Japan]) of the heart, brain, and abdomen was performed before the entry in the study and after each dose of treatment by trained physicians. Physicians performing echocardiography and making the decision for secondand third-dose administration were unaware of assignment. The purpose was to confirm the presence of a left-to-right ductal shunting, to evaluate its degree, and to measure the internal diameter of the ductus. Shunting was graded as minor if a disturbed diastolic flow was scarcely detectable in the main pulmonary artery, and there was no diastolic backflow in the aorta immediately beneath the ductus arteriosus. It was graded as moderate if a disturbed diastolic flow was easily detectable in the main pulmonary artery, and there was a diastolic backflow in the aorta immediately beneath the ductus arteriosus. It was graded as severe if a diastolic backflow was easily detectable in the pulmonary trunk and in the aorta with a left-atrium-to-aortic-root ratio of Ͼ1.6, and if diastolic backflow was detectable in the medium cerebral artery or in the superior mesenteric artery or in the renal arteries. 6 If shunting was graded as moderate or severe, PDA was considered hemodynamically significant. Cranial ultrasound examination was performed, first before entering the study, then repeated after each dose, 1 week after the last dose and before discharge. The study patients were assessed for IVH and for periventricular leukomalacia (PVL) which were graded, respectively according to classifications of Papille and of de Vries, with higher grades indicating greater severity. 7, 8 
Concomitant Treatment
For all patients enrolled in the study, fluid intake was begun at 70 mL/kg per day with increases by increments of 10 mL/kg each day to a maximum of 120 mL/kg per day by the end of the study. Dopamine infusion at the dose of 3 g/kg per minute was started once urine output deer Յ1 mL/kg per hour. Intravenous furosemide at a loading dose of 2 mg/kg was prescribed in case of radiologic evidence of pulmonary edema. Ventilatory support was imposed by the severity of the respiratory distress and included nasal continuous positive airway pressure, intermittent positive pressure ventilation, and high-frequency oscillatory ventilation. Nasal continuous positive airway pressure was used as the first step. Intermittent positive pressure ventilation was indicated once arterial to alveolar ratio for oxygen pressure was Ͻ0.15, arterial partial pressure of carbon dioxide was Ͼ65 mm Hg, or in case of recurrent apnea. Highfrequency oscillatory ventilation was indicated as a last resort when arterial to alveolar ratio was Ͻ0.10 or when alveolar pathology required ventilator peak inspiratory pressure of Ͼ24 cm H 2 O. Inhaled nitric oxide was used to treat persistent pulmonary hypertension. Surfactant (Curosurf, Chiesi, Italy; a vial of 1.5 mL containing 120 mg) was administered intratracheally at the dosage of 100 to 200 mg/kg prophylactically (infants at Ͻ27 weeks' gestation) and as a very early rescue (infants Ͼ27 weeks' gestation) when arterial to alveolar ratio was Ͻ0.25. Prophylactic antibiotics (cefotaxime, ampicillin, and amikacin) were started on admission and discontinued 2 days later if infectious tests were negative.
Early Outcome
Because it is difficult to relate some multifactorial complications to ibuprofen treatment, we considered 1 week after the administration of the last dose as a limit for the implication of ibuprofen in some complications. During this week, all patients enrolled in the study were prospectively assessed for ductal closure, number of doses required, mode and duration of ventilation, surfactant treatment, renal failure, IVH, NEC, and GEB. NEC was graded according to Bell's classification. 9 Late Outcome After the week of treatment, the patients were assessed for IVH, NEC, CLD, PVL, nosocomial sepsis, duration of hospital stay, time to regain birth weight, time to full enteral feeding, and death. CLD was defined according to the new Bancalari's classification, which differentiated 3 groups of preterm infants on the basis of treatment with supplemental oxygen at 28 days and 36 weeks. 10 
Statistical Analysis
We calculated that a study group of 62 patients would be necessary for the study to be able to detect a difference of at least 25 percentage points in the closure rate between the oral ibuprofen and intravenous ibuprofen groups, assuming a closure rate of 65% with intravenous ibuprofen, with a P value of .05 and a power of 80%. Continuous data are presented as mean Ϯ SD. Comparisons between groups were performed by using independent-samples t test for parametric continuous variables, Wilcoxon rank-sum test for nonparametric continuous variables, and Fisher's exact and 2 tests for categorical variables.
RESULTS
The number of patients who were eligible for the study, who were excluded and who were randomly assigned to receive oral ibuprofen or intravenous ibuprofen, are shown in Fig 1. There were no significant differences between the 2 groups in baseline clinical characteristics (Table 1) . In each group, 75% of the patients were born after 28 weeks' gestation.
Efficacy of Treatment
The rate of closure of PDA was marginally favorable in group O (84.3% vs 62.5%, P ϭ .04; 95% confidence interval: 0.99 -1.84). Surgical ligation of the PDA was performed in 1 (3.1%) patient in group O and in 4 (12.5%) patients in group I (P ϭ .25). There was no reopening of the ductus after closure was achieved. In 3 (9.3%) patients in group O and in 4 (12.5%) patients in group I, a minor ductal shunting persisted after therapy. In all these patients, the ductus closed spontaneously. Furosemide was prescribed in 4 patients in each group.
The number of doses needed in both groups did not differ (1.9 Ϯ 0.2). Closure of the ductus was obtained after 1 dose of treatment in 11 and 8 patients, after 2 doses in 8 and 6 patients, and after 3 doses in 8 and 6 patients of groups O and I, respectively. On the other hand, there were no differences between failure of therapy groups (Table 2 ). In each group, when the therapy failed, the ductus shunting was severe.
Early Outcome
During the week after treatment, oliguria developed in no patient in group O and in 3 patients in group I (P ϭ .23). An increase in serum creatinine level Ͼ16 mg/dL was observed in 3 patients in group I and in no patient in group O (P ϭ .23). The change in creatinine concentrations in group O versus group I was 5.7 Ϯ 1.2 mg/dLversus 10.9 Ϯ 1.2 mg/dL (P Ͻ .01). Dopamine infusion was prescribed in 1 patient in group O and in 3 patients in group I. There were no differences between groups in the incidence of IVH 1-2 (n ϭ 3 vs 3), IVH 3-4 (n ϭ 1 vs 1), NEC (n ϭ 2 vs 1), and bowel perforation (Ø vs Ø).
Late Outcome
Survival at 1 month was similar in the 2 groups (71.9% vs 75%; P ϭ 1). When we consider all the duration of hospital stay, there were no significant differences between the treatment groups in, CLD (2 vs 3), NEC (4 vs 3), IVH (13 vs 12; P ϭ .78), PVL (2 vs 2), sepsis (10 vs 9), and duration of intubation (5.7 Ϯ 1.1 vs 5.1 Ϯ 1.2 days). Mean duration of hospital stay was 37.5 Ϯ 6.3 days in group O versus 39.5 Ϯ 5.5 days in group I.
DISCUSSION
On the basis of our data, it seems that the rate of early ductal closure in VLBW infants is at least as effective 
FIGURE 1
Enrollment.
with oral ibuprofen in comparison to the intravenous route. This is the first randomized study, to our knowledge, comparing oral ibuprofen and intravenous ibuprofen in closure of PDA. The rate of closure in the group assigned to intravenous ibuprofen was similar to rates previously reported. 6, 11 Some trials on the use of oral ibuprofen for closure of PDA have been recently published. 5, [12] [13] [14] [15] [16] [17] [18] All studies had small sample sizes. Aly, 14 in a randomized pilot study, reported that PDA was closed in 7 of 9 premature infants (Յ35 weeks) given oral ibuprofen and in 10 of 12 premature infants given intravenous indomethacin (P ϭ .75). Fakhraee, 16 in a randomized study, reported that PDA was closed in all of 18 premature infants (Յ34 weeks) given oral ibuprofen and in 15 of 18 premature infants given oral indomethacin (P Ͼ .05). Efficacy of oral ibuprofen compared with intrave- nous indomethacin, was reported by Supapannachart et al 13 and Chotigeat et al, 15 as well. In nonrandomized open trials, Heyman et al, 17 Cherif et al, 5 and Hariprasad et al 17 reported a ductal closure with oral ibuprofen respectively in 21 (95.4%) of 22 patients, 38 (95%) of 40 patients, and in 11 (84.6%) of 13 patients. The authors concluded that oral ibuprofen might constitute a feasible alternative in the treatment of PDA.
There are not enough studies on pharmacokinetics of oral ibuprofen in premature infants. Raju et al 19 reported, in a pilot study including a small number of premature infants, that ibuprofen was absorbed rapidly after oral administration, and peak concentrations in plasma were observed after 1 to 2 hours. Sharma et al 20 reported a wide interindividual variability for plasma concentrations, elimination half-life, and area under the plasma concentration-time curve. In our study, ibuprofen plasma levels were not measured. The slower absorption of oral ibuprofen, compared with the intravenous route, and the longer half-life probably prolonged the time of contact with the ductus leading to a higher responsiveness.
Closure of the ductus, in our study, was obtained after 1 or 2 doses of treatment, in 70% of both groups. The regimen commonly used is 10 ϩ 5 ϩ 5 mg/kg of ibuprofen every 24 hours. This regimen was based on the finding of Aranda and Varvarigou. 21, 22 The small number of patients (10 in the study of Aranda and 11 in the study of Varvarigou) and the wide interindividual variability of ibuprofen plasma concentrations make these findings debatable. Although, this regimen was confirmed by the double-blind dose finding study of Desfrere et al, 23 it is not excluded that, if closure can be obtained with only 1 or 2 doses, the tolerability and safety of the treatment will probably be better. Indeed, in our study, the adverse effects were significantly fewer when the closure was achieved after an incomplete course of treatment. In each group, when the closure of the ductus was obtained with an incomplete course, the ductal shunting was moderate, suggesting that ibuprofen regimen could be reviewed according to degree of ductal shunting. In their article, Aranda et al 21 reported that it was unclear whether high maintained plasma concentrations of ibuprofen were necessary for ductal closure. In our previous open trial, 5 closure of the ductus with incomplete course of oral ibuprofen was obtained in 34 (89.4%) of 38 patients. Similarly, in the open trial of Heyman et al, 17 closure of the ductus with incomplete course of oral ibuprofen was obtained in 20 (95.2%) of 21 patients. A randomized, controlled regimen-finding study should be performed.
The adverse effects, in our study, were fewer in group O (9.3% vs 31.2%). Although the calculated P value was significant (.02), the 95% confidence interval for the relative risk (1.01-11.00) does not support a significant difference. The adverse effects in group I were similar to those previously reported. 6, 11 Although renal failure was reported with intravenous ibuprofen at rates ranging from 6.8% to 57%, 6, 11, 22, [24] [25] [26] [27] [28] it was reported by no study using oral ibuprofen. 5, [12] [13] [14] [15] [16] [17] [18] However, Tiker and Yildirim 29 reported an anecdotal observation on transitional renal impairment in a 880 g, 29 weeks old infant given simultaneously a complete course of oral ibuprofen and aminoglycoside. Neither blood ibuprofen level nor aminoglycoside blood level was measured. In our study, renal failure was observed in 3 (9.3%) patients in group I versus none (0%) in group O. Rates of NEC reported with intravenous ibuprofen varied from 4.5% to 17%. 6, 11, 22, [24] [25] [26] [27] [28] In a pool of 151 patients treated with oral ibuprofen, NEC was reported in12 (7.9%) cases. 5, [12] [13] [14] [15] [16] [17] [18] Tatli 30 reported 2 cases of spontaneous intestinal perforation after oral ibuprofen treatment for PDA in 2 VLBW infants, but did not precise the osmolality and pH of the suspension used. It seems that intravenous ibuprofen was simply used orally, which is so different from a suspension intended for oral route. Recent concerns raised over oral ibuprofen because of its high osmolality. 31 In our study, NEC was observed in 1 (3.1%) patient in group I versus 2 (6.2%) patients in group O (P ϭ 1). The osmolality of the ibuprofen suspension was 312 mosmol/L, and the pH was 5.8, both of which are not associated with gastrointestinal irritation. None of our patients had bowel perforation. In published, randomized, clinical trials, no case of GEB was reported with intravenous ibuprofen. In a pool of 151 patients treated with oral ibuprofen, GEB was reported in 19 cases (12.6%). In our study, GEB developed in 1 patient in group O and in no patient in group I. The rate of IVH reported with intravenous ibuprofen in our study was similar to those reported previously. 6, 11, 22, [24] [25] [26] [27] [28] Finally, there are several limitations to our study. The study was not powered to detect differences in complications. Larger sample size could also detect significance between groups in efficacy. The study would have been strengthened by measuring the blood levels of ibuprofen in both groups. Despite these limitations, study adds valuable information on the feasibility of using oral ibuprofen for PDA closure in premature infants.
CONCLUSIONS
Our data indicate that, for VLBW infants, the rate of early ductal closure was comparable and the adverse effects were fewer with oral ibuprofen in comparison to the intravenous route, but the differences were not statistically significant. A larger sample study is certainly needed for more definitive conclusion. On the other hand, our data suggest that ductal closure may be obtained with incomplete course of ibuprofen. A regimenfinding, well-designed study should be performed to confirm this trend.
